Cargando…
Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993996/ https://www.ncbi.nlm.nih.gov/pubmed/17319452 |
_version_ | 1782135464465006592 |
---|---|
author | Tabrizchi, Reza |
author_facet | Tabrizchi, Reza |
author_sort | Tabrizchi, Reza |
collection | PubMed |
description | |
format | Text |
id | pubmed-1993996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-19939962008-03-06 Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors Tabrizchi, Reza Vasc Health Risk Manag Editorial Foreword Dove Medical Press 2006-06 2006-06 /pmc/articles/PMC1993996/ /pubmed/17319452 Text en © 2006 Dove Medical Press Limited. All rights reserved |
spellingShingle | Editorial Foreword Tabrizchi, Reza Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors |
title | Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors |
title_full | Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors |
title_fullStr | Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors |
title_full_unstemmed | Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors |
title_short | Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors |
title_sort | risk of cardiovascular events and cyclooxygenase-2 inhibitors |
topic | Editorial Foreword |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993996/ https://www.ncbi.nlm.nih.gov/pubmed/17319452 |
work_keys_str_mv | AT tabrizchireza riskofcardiovasculareventsandcyclooxygenase2inhibitors |